News
The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...
The GOP-led House Judiciary Committee is investigating allegations that Pfizer delayed its COVID-19 vaccine testing until ...
On Nov. 9, 2020, Pfizer and partner BioNTech announced that the vaccine had met the first effectiveness bar in a key study.
14d
Scripps News on MSNHHS, NIH announce development of universal vaccine for COVID-19 and influenzaResearchers aim to develop a universal vaccine platform that could protect against both COVID-19 and influenza without annual ...
The GOP-led House Judiciary Committee is investigating Pfizer's COVID-19 vaccine development timeline. They are focusing on allegations that vaccine testing results were delayed until after the 2020 ...
Invivyd, Inc. has submitted a Citizen Petition to the FDA advocating for a new approach to the development of COVID-19 vaccines and monoclonal antibodies (mAbs) to restore public trust in health ...
and comprehensive preparedness," by focusing on "in-house development" of vaccines instead of projects from outside researchers. It is also planning to develop other vaccines for COVID-19 using ...
The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...
6d
News-Medical.Net on MSNOxford study reveals how COVID-19 vaccines prevent severe illnessA landmark study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.
Rudman Spergel, MD, director of clinical development at Moderna ... the technology to create one of the world’s first COVID-19 vaccines. In 2023, the company announced results from a phase ...
SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the "Company" or "Vaxart") today announced its business update and financial results for the first quarter of ...
Messenger Ribonucleic Acid (mRNA) vaccines gained global recognition during the Coronavirus Disease 2019 (COVID-19) pandemic, proving their value through rapid development, high efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results